Human Formulations

Rivaroxaban 2.5mg Tablet (film coated)

Rivaroxaban 2.5mg Tablet (film coated) is a tablet formulated with Rivaroxaban 2.5mg ( ). The listed active ingredient profile is Rivaroxaban, placing the product in the anticoagulant category. The active medicine reduces blood-clot formation through anti

Therapeutic RangesCardiac Range Single Ingredient Tablet
Sterile injectable formulation

Product information

Product Line
Human Formulations
Category
Therapeutic Ranges, Cardiac Range
Dosage Form
Tablet
Product Type
Single Ingredient

Available strengths

Rivaroxaban 2.5mg ( )Rivaroxaban 5mg ( )Rivaroxaban 10mg ( )Rivaroxaban 15mg ( )Rivaroxaban 20mg ( )

Description

Rivaroxaban 2.5mg Tablet (film coated) is a tablet formulated with Rivaroxaban 2.5mg ( ). The listed active ingredient profile is Rivaroxaban, placing the product in the anticoagulant category. The active medicine reduces blood-clot formation through anticoagulant activity and requires careful prescription-led use. The source identifies the dosage form as tablet with film coated presentation. For website cataloguing, the composition, strength, dosage form and formulation characteristics should be displayed prominently and consistently. The product description should remain factual and should not include unapproved cure, superiority, guaranteed-result or broad therapeutic claims. Clinical selection should depend on diagnosis, patient-specific factors, contraindications, concomitant medicines and professional judgement. Prescription status, warnings, interactions, adverse effects and dosing or application instructions must be checked against the current approved product label. Manufacturer, licence, storage, shelf-life, reconstitution where applicable, and market-specific regulatory details should be added only from verified product documentation.
WHO-GMP Sourced
Sterile Supply
Regulatory Documentation
Quality Assured